Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1988-9-22
|
pubmed:abstractText |
Cervical re-exploration in persistent medullary thyroid cancer usually fails to normalize serum calcitonin levels, which is the most sensitive criterion of tumour-free status (2 out of 21 patients in our re-exploration series). Positive lymph nodes - even at an early tumour stage - seem much more important (postoperative normal serum calcitonin: 86% in the occult tumour group, 71% in patients with palpable primary tumour and negative lymph nodes, as opposed to only 18% with a palpable cervical mass and positive lymph nodes). However, local re-exploration in case of persistent medullary thyroid cancer seems to offer a possible curative chance for the control of recurrence, especially after inadequate primary surgery. In cases without visible distant metastases a marked reduction in serum calcitonin level may be expected (21% of the preoperative level for stages N1 and N2 and 16% for stage N3 on average). In patients with elevated calcitonin levels after stimulation as sole indicator of persistent tumour the indication for reoperation should be handled cautiously. Thus, in 3 out of 5 patients with occult medullary thyroid cancer diagnosed only on the basis of venous sampling who were subjected to multiple cervical re-explorations, distant metastases were subsequently found during follow-up.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0043-5325
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
348-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2900580-Calcitonin,
pubmed-meshheading:2900580-Carcinoma,
pubmed-meshheading:2900580-Follow-Up Studies,
pubmed-meshheading:2900580-Humans,
pubmed-meshheading:2900580-Lymphatic Metastasis,
pubmed-meshheading:2900580-Multiple Endocrine Neoplasia,
pubmed-meshheading:2900580-Neoplasm Recurrence, Local,
pubmed-meshheading:2900580-Thyroid Neoplasms
|
pubmed:year |
1988
|
pubmed:articleTitle |
[Reintervention in C-cell carcinoma].
|
pubmed:affiliation |
Chirurgische Klinik, Bürgerhospital Frankfurt, Bundesrepublik Deutschland.
|
pubmed:publicationType |
Journal Article,
English Abstract
|